Navigation Links
Clinical Data & Innovation Will Shift PCI and CABG Procedures in Europe

By 2013, over 685,000 PCI and 165,000 CABG procedures will be performed, according to Millennium Research Group

WALTHAM, Mass., May 14 /PRNewswire/ -- According to two new Millennium Research Group (MRG) reports, emerging clinical data and innovations in device technology will shift the balance between percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) procedures for unique subgroups with coronary artery disease through 2013. MRG's European Markets for Interventional Cardiology Devices 2009 and European Markets for Coronary Artery Bypass Graft Devices 2009 reports indicate that by 2013, over 685,000 PCI procedures and over 165,000 CABG procedures will be performed across Europe.

Results of clinical studies supporting the benefits of PCI will expand the eligible patient population to include higher-risk subgroups, which until recently have been untreated by PCI. In 2008, results of the CARDia trial identified similar rates of myocardial infarction, stroke, or death at 12 months in diabetic patients who received either PCI or CABG surgery. Initial results of the SYNTAX trial found the same trend for patients with complicated forms of CAD. Consequently, while CABG surgery will remain the gold standard treatment for complex CAD, some of these patients may now be considered eligible for PCI.

"Results of recent clinical studies demonstrate that PCI can be used to treat patients with significantly more complicated forms of CAD than previously thought possible," says Anuk Karunaratne, Senior Analyst at MRG. "Innovations in PCI technology -- such as improved stent design and intravascular ultrasound (IVUS) -- will enable treatment of more complicated cases and will allow PCI use to expand further into CABG territory, although it's unlikely that referral patterns will shift significantly in the short-term. Nevertheless, continued innovation and clinical data will influence physicians to select PCI as the optimal treatment for some higher-risk patients."

MRG's new reports, European Markets for Interventional Cardiology Devices 2009 and European Markets for Coronary Artery Bypass Graft (CABG) Devices 2009 cover France, Germany, Italy and the UK, and also provide data such as usage rates, units per procedure, average selling prices, and growth rates. Detailed market shares are provided across all market segments for key companies, including Abbott Vascular, Boston Scientific, Johnson & Johnson's Cordis, Medtronic, Sorin Group, Terumo Medical, Volcano, and more.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through syndicated reports, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101

    Elizabeth Marshall
    Decision Resources Inc.

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
Breaking Medicine Technology: